Sorted By:

Relevance


ICYMI: Has the 340B Program Lost Its Way?

PhRMA  |  Blog Post

” Rapid growth of contract pharmacy arrangements.
http://catalyst.phrma.org/icymi-has-the-340b-program-lost-its-way

Medicare Monday: A closer look at Part B spending

PhRMA  |  Blog Post

While the Medicare Part B program helps ensure patients can access these complex, innovative medicines, it also works to moderate spending.
http://catalyst.phrma.org/medicare-monday-a-closer-look-at-part-b-spending

Australia’s opportunity to lead the TPP forward

PhRMA  |  Blog Post

But innovative drug-makers are not going to invest in Australia if their discoveries, their IP, are better protected elsewhere; they may not even apply to sell their products there.
http://catalyst.phrma.org/australia-s-opportunity-to-lead-the-tpp-forward

Nuevos Informes Destacan el Aumento de la Competencia Global en I + D Biofarmacéutica, Planteando Desafíos Significativos para la Futura Posición de Estados Unidos

PhRMA  |  Press Release

"Si miramos hacia el futuro, vemos que las compañías biofarmacéuticas innovadoras de nuestra nación están comprometidas a asociarse con escuelas de todos los niveles en todo el país para desarrollar la próxima generación de científicos, ingenieros y técnicos que son críticos para avanzar en nuevos tratamientos y curas", añadió la Dra.
https://www.phrma.org

Medicare Monday: How Part D helps patients with heart disease live longer, healthier lives

PhRMA  |  Blog Post

We must protect Part D from harmful proposals that could restrict beneficiary access to medicines.
http://catalyst.phrma.org/medicare-monday-how-part-d-helps-patients-with-heart-disease-live-longer-healthier-lives

Guess what? Part B drug spending remains stable share of Medicare spending

PhRMA  |  Blog Post

It is also important to note that the Part B program continues to evolve as it is incorporated into innovative payment designs like Accountable Care Organizations and the Oncology Care Model.
http://catalyst.phrma.orghttps://catalyst.phrma.org/guess-what-part-b-drug-spending-remains-stable-share-of-medicare-spending

Consumers Still Pay Bigger Share For Healthcare Than Government And Businesses

Access Better Coverage  |  From Our Network

And 23% of income for the median household was needed to pay premiums for family coverage in 2013, up from 21% in 2010.
http://www.accessbettercoverage.org/social-news/consumers-still-pay-bigger-share-for-healthcare-than-government-and-businesses

Samantha Budd, PhD

PhRMA  |  Biography

Samantha has a BSc and PhD in Biochemistry from the University of Dundee in Scotland, and conducted research at the Neurosurgery Department, Brigham & Women’s Hospital, Harvard Medical School in Boston, and The Center for Neuroscience Research at The Burnham Institute in San Diego.
https://www.phrma.org/biography/samantha-budd-phd

Lung-MAP: Personalized Medicine is Driving a New Clinical Research Paradigm

Chartpack  |  From Our Network

Lung-MAP (Lung Cancer Master Protocol) uses genomic profiling to match patients to specific investigational personalized medicines, all under one umbrella study.
http://chartpack.phrma.org/personal-medicines-in-development-chartpack/an-evolving-pipeline/lung-map-personalized-medicine-is-driving-a-new-clinical-research-paradigm

Home Page Carousel Test

Access Better Coverage  |  From PhRMA

...
http://www.accessbettercoverage.org/home-page-carousel-test

Medicare Monday: What is ASP?

PhRMA  |  Blog Post

In a future post, we will explore the effect of sequestration, which reduced Medicare reimbursement for Part B covered drugs to ASP+4.3 percent.
http://catalyst.phrma.org/medicare-monday-what-is-asp

Medicare Monday: Billing code basics for biologics in Part B

PhRMA  |  Blog Post

Learn more about Medicare Part B at PhRMA.org/PartB.
http://catalyst.phrma.org/medicare-monday-billing-code-basics-biologics-part-b

Paul Aines

PhRMA  |  Biography

He started his career on the audit staff at professional services company KPMG LLP.
https://www.phrma.org/biography/paul-aines

Medicare Monday: Medicare turns 52!

PhRMA  |  Blog Post

In its first 11 years, Part D has: Contributed to decreased mortality rates for seniors each year since its implementation.
http://catalyst.phrma.org/medicare-monday-medicare-turns-52

Medicare Monday: CMS withdraws Part B demo, takes positive step forward on CMMI

PhRMA  |  Blog Post

Before issuing any new demos, CMMI should carefully consider the feedback received as part of this process.
http://catalyst.phrma.org/medicare-monday-cms-withdraws-part-b-demo-takes-positive-step-forward-on-cmmi

Why Do Patients Have to Pay Thousands of Dollars in Prescription Medicine Costs Before Coverage Begins?

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/why-do-patients-have-to-pay-thousands-of-dollars-in-prescription-medicine-costs-before-coverage-begins

Understanding Medicare Part B Pocket Card

PhRMA  |  Report

Medicare Part B covers physician office visits, outpatient care, ambulance services and medical equipment.
https://www.phrma.org/report/understanding-medicare-part-b-pocket-card

Medicare Monday: It is Medicare’s birthday month!

PhRMA  |  Blog Post

We’ve looked at the history of Medicare and broken down the details on our website.
http://catalyst.phrma.org/medicare-monday-it-is-medicares-birthday-month

ICYMI: Wall Street Journal and Washington Post Say TPP Should Protect Medical Innovation

PhRMA  |  Blog Post

Any trade deal “has to protect the fruits of innovation in the information economy,” the Journal finishes.
http://catalyst.phrma.org/icymi-wsj-and-washington-post-say-tpp-should-protect-medical-innovation

New PwC report finds medicine spending still small share of health spending, concerns may trigger ‘false alarms’

PhRMA  |  Blog Post

” In addition, HRI projects that continued aggressive negotiations by pharmacy benefit managers (PBMs) will further control costs and that when there is competition among medicines in a class, PBMs can negotiate more significant discounts and rebates.
http://catalyst.phrma.org/new-pwc-report-finds-medicine-spending-still-small-share-of-health-spending-concerns-may-trigger-false-alarms

Milliman Report: Reducing Part D Beneficiary Costs through Point-of-Sale Rebates

PhRMA  |  Report

PhRMA engaged Milliman to assess the impact of changing pharmacy and manufacturer rebates to the POS.
https://www.phrma.org/report/milliman-report-reducing-part-d-beneficiary-costs-through-point-of-sale-rebates

Negotiators Must Say “Aloha” to a 21st Century Trade Deal

PhRMA  |  Blog Post

As negotiators embark upon this pivotal week, they must keep in mind the role innovation will play in the future global economy.
http://catalyst.phrma.org/negotiators-must-say-aloha-to-a-21st-century-trade-deal

Many Patients with Exchange Coverage to Pay More than Twice As Much Out Of Pocket for Prescriptions Compared to Employer Plans

PhRMA  |  Press Release

The firm has consulting practices in healthcare, property & casualty insurance, life insurance and financial services, and employee benefits.
https://www.phrma.org/press-release/many-patients-with-exchange-coverage-to-pay-more-than-twice-as-much-out-of-pocket-for-prescriptions-compared-to-employer-plans

Some Health Insurance Exchange Plans Put All Treatments for Certain Diseases on Top Cost-Sharing Tier

PhRMA  |  Blog Post

This report is evidence that for many, that opportunity has not been realized.
http://catalyst.phrma.org/some-health-insurance-exchange-plans-put-all-treatments-for-certain-diseases-on-top-cost-sharing-tie

Nikhil V. Dhurandhar, PhD

PhRMA  |  Biography

Dhurandhar has received research funding from the NIH, American Diabetes Association, Federal Emergency Management Agency, and other non-profit or commercial funding sources, has published over 100 scientific articles, and book chapters, and served as a mentor or advisor for several students and postdoctoral fellows.
https://www.phrma.org/biography/nikhil-v-dhurandhar-phd

You have reviewed the first 100 results out of 2221. Each page contains 25 results. You're on page 4.

prev 1 2 3 4 5 6 next